SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Lidak Pharm. [LDAKA]

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: luis a. garcia who wrote (775)1/2/1998 8:53:00 PM
From: John Zwiener  Read Replies (1) of 1115
 
Luis and Henry,
It's a little encouraging that Lidak drifted up from it's open. It would be interesting to know if the short sellers decreased their position today. The upward drift and decrease in short sellers (if that's what happened today) would indicate that the placebo numbers are OK.
I was frankly surprised that the price did not drop down to around 1. I continue to hold.
I do not think that the possible use for Kaposi's sarcoma has anything to do with BMY dropping lidakol. Conflict of interest? Kaposi's use is small change compared to the Herpes use. And it seems that every drug company in the world is working on a treatment for Kaposi's.
Luis, acyclivir only decreases an outbreak by 1/2 day. It barely worth the trouble to take this expensive drug, but it is a 1.5 billion dollar drug for the herpes use.
The only reason I continue to hold is my impression of the people at lidak. But the numbers tell the story.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext